Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

Cyst induction and growth in ADPKD

$4.91M USD

Funder NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
Recipient Organization Cincinnati Childrens Hosp Med Ctr
Country United States
Start Date Aug 15, 2024
End Date May 31, 2029
Duration 1,750 days
Number of Grantees 1
Roles Principal Investigator
Data Source NIH (US)
Grant ID 10976067
Grant Description

Abstract: Autosomal Dominant Polycystic Kidney Disease (ADPKD) is one of the world’s most common life-threatening genetic diseases. Mutations in the genes PKD1 and PKD2 account for 85% and 15% of all ADPKD cases, respectively. ADPKD patients are heterozygous for either PKD1 or PKD2 deleterious mutations; homozygous

mutations are considered incompatible with life. Interestingly, loss-of-heterozygosity studies and genome sequencing of patients’ cysts, have documented the clonal nature of the epithelial cysts in ADPKD. Altogether, these data support the two-hit model in which one mutation in either PKD1 or PKD2 is inherited, but a second

(somatic) mutation is required for the clonal expansion of the epithelial cells and progression of cystic disease. While these data strongly support the two-hit model, there is scarce data reporting if, when, and how, a second mutation in an individual renal cell affects the behavior of that cell and its environment in vivo.

We have generated a series of mouse lines that recapitulates the two-hit model. In an otherwise Pkd2 heterozygous animal, we can induce a second mutation during embryonic development but also at later timepoints. Our data confirms that single mutant cells are responsible for the generation of cysts and that all

cells in the cyst arise from the originally mutated cell. Most importantly, our data reveals that not all mutant cells become cysts. We hypothesize that cyst inception is modulated by additional intrinsic and extrinsic factors affecting mutant cells. Specifically, we hypothesize that cyst inception and/or growth is driven by tubular identity, external

sources of proliferation and the microenvironment created by the chimeric nature of the disease. We will test these hypotheses in three aims employing mouse models as well as kidney explants and iPSC-derived kidney organoids.

All Grantees

Cincinnati Childrens Hosp Med Ctr

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant